Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy

Bo TIAN; Chongxi LI; Yongmei JIN; Wei GUAN; Haiyun CHEN; Jun LIU

doi:10.12259/j.issn.2095-610X.S20230508

Volume 44 Issue 5

May 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(5): 162-167

Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy[J]. Journal of Kunming Medical University, 2023, 44(5): 162-167. doi: 10.12259/j.issn.2095-610X.S20230508

Citation:

Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy[J]. Journal of Kunming Medical University, 2023, 44(5): 162-167. doi: 10.12259/j.issn.2095-610X.S20230508

Citation:

PDF( 752 KB)

Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy

doi: 10.12259/j.issn.2095-610X.S20230508

The Third People’s Hospital of Kunming/ Yunnan Clinical Medical Center for Infectious Diseases. Kunming Yunnan 650041，China

Received Date: 2022-10-25
Available Online: 2023-05-11
Publish Date: 2023-05-25

Abstract

Abstract

Objective To understand the use of primary and menstrual ART regimens for HIV patients receiving antiviral treatment in different periods, and to analyze the dressing change situation and reasons of different drug combinations. Methods Patients initially enrolled in ART from January 2017 to June 2022 were included in the study. The demographic characteristics and the changes of the primary and menstrual ART regimens of the participants in different periods were analyzed and the differences in dressing change rates between the different regimens were compared. Results Most of the subjects were male, The average age was 41.35±14.2 years old and there was an increasing trend （P < 0.001）. TDF/AZT+3TC+EFV was the main ART regimens in newly diagnosed patients, but the utilization rate decreased after the treatment. The TDF+3TC+EFV regimen had the highest dressing change rate （17.3%）. Compared with the initial treatment, the utilization rate of the protocol containing LPV/r increased. Integrase-containing regimens increased significantly in the treated patients in 2021 and early 2022 （P < 0.001）. Drug change rates did not differ at 1, 2, 3, 4, and 5 years of treatment （P = 0.376）. The main reason for dressing change was drug side effects （57.4%）. Conclusion The selection of ART drugs gradually switches from nucleoside and non-nucleosides to integrase inhibitors.The choice of ART drugs is gradually changing from the nucleoside non-nucleoside to integrase inhibitor, which tends to be individualized. Combining the clinical characteristics and complications of patients and choosing the most efficient, low-toxic and simple scheme are more conducive to the long-term effective treatment of patients.
- HIV,
- AIDS,
- ART,
- Programme,
- Change of dressing

FullText(HTML)

References(16)

References

[1]	张福杰,赵燕,马烨,等. 中国免费艾滋病抗病毒治疗进展与成就[J]. 中国艾滋病性病,2022,28(1):6-9.
[2]	E Jennifer,Edelman,Kirsha,et al. The next therapeutic challenge in HIV: Polypharmacy[J]. Drugs Aging,2013,30(8):613-628. doi: 10.1007/s40266-013-0093-9
[3]	中国疾病预防控制中心,中华医学会感染病学分会艾滋病丙型肝炎学组. 中国艾滋病诊疗指南(2021年版)[J]. 中国艾滋病性病,2021,27(11):1182-1201.
[4]	凌雪梅,蔡卫平,钟活麟,等. DTG 3TC简化方案真实世界临床疗效与安全性研究[J]. 传染病信息,2022,35(1):51-55.
[5]	Sophie Abgrall,Suzanne M Ingle,Margaret T May,et al. Durability of first ART regimen and risk factors for modification,interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009[J]. AIDS,2013,27(5):803-813. doi: 10.1097/QAD.0b013e32835cb997
[6]	韦黎娟. 艾滋病初始抗病毒治疗方案更换原因分析[D]. 南宁: 广西医科大学硕士学位论文, 2019.
[7]	陈美玲,吴亚松,赵德才,等. 艾滋病抗病毒治疗的换药率比较及其影响因素[J]. 中华传染病杂志,2017,35(4):193-197.
[8]	Sun J,Liu L,Shen J,et al. Reasons and risk factors for the initial regimen modification in Chinese treatment-naive patients with HIV infection:A retrospective cohort analysis[J]. PLoS One,2015,10(7):e0133242. doi: 10.1371/journal.pone.0133242
[9]	楼金成,周曾全,劳云飞,等. 含克力芝的ART方案在早期初治成人HIV/AIDS病人中的疗效及终止治疗情况[J]. 中国艾滋病性病,2017,23(9):802-805.
[10]	Pedro Cahn,Juan Sierra Madero,Jose Ramon Arribas,et al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): Week 48 results from two multicentre,double-blind,randomised,non-inferiority,phase 3 trials[J]. Lancet,2019,393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0
[11]	Pedro Cahn,Juan Sierra Madero,Jose Ramon Arribas,et al. Durable efficacy of dolutegravir plus lamivudine in antiretroviral treatment-naive adults with HIV-1 infection:96-week results from the GEMINI-1 and GEMINI-2 randomized clinical trials[J]. J Acquir Immune Defic Syndr,2020,83(3):310-318. doi: 10.1097/QAI.0000000000002275
[12]	Woldemedhin B,Wabe N T. The reason for regimen change among HIV/AIDS patients initiated on first Line highly active antiretroviral therapy in Southern Ethiopia[J]. North American Journal of Medical Sciences,2012,4(1):19-23.
[13]	Scherzer,Estrella,Choi,et al. Association of tenofovir exposure with kidney disease risk in HIV infection[J]. AIDS,2012,26(7):867-875. doi: 10.1097/QAD.0b013e328351f68f
[14]	Nduka C U,Stranges S,Kimani P K,et al. Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV-infected patients? A meta-analysis[J]. Diabetes Metab Res Rev,2017,33(6):2902. doi: 10.1002/dmrr.2902
[15]	Tseng A,Szadkowski L,Walmsley S,et al. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients[J]. Ann Pharmacother,2013,47(11):1429-1439. doi: 10.1177/1060028013504075
[16]	赵海,潘锋. 艾滋病防治进入全病程管理新时代-访北京协和医院感染内科主任李太生教授[J]. 中国医药科学,2022,12(1):1-5. doi: 10.3969/j.issn.2095-0616.2022.01.001

Relative Articles(20)

Relative Articles

[1]	Xuelin XIANG, Hongrui ZHAO, Zhongjie WANG, Yu XIA, Min MA, Huadan WANG, Liping. HE. Social Support Status and Influencing Factors of HIV-infected Patients on Antiviral Therapy. Journal of Kunming Medical University, 2024, 45(9): 156-162. doi: 10.12259/j.issn.2095-610X.S20240924
[2]	Qian AI, Zhirong ZHAO, Yue WU, Haiwen LI, Shenghao LI, Yongrui YANG. Analysis of Antiviral Efficacy and Safety in Patients with Chronic Hepatitis B in Indeterminate Phase. Journal of Kunming Medical University, 2024, 46(): 1-9.
[3]	Bo TIAN, Yongmei JIN, Haiwen LI, Chongxi LI, Wei ZHANG, Wei GUAN, Haiyun CHEN, Qi XUE, Huirong YANG, Jun LIU. Analysis of the Current Status and Influencing Factors of Metabolic Syndrome in Patients Undergoing Antiretroviral Therapy for AIDS. Journal of Kunming Medical University, 2024, 45(11): 149-154. doi: 10.12259/j.issn.2095-610X.S20241121
[4]	Yihan LIU, Jun LIU, Yongmei JIN, Bo TIAN, Jinsong BAI. Risk Assessment and Analysis of Risk Factors for Cardiovascular Disease in HIV Antiviral Therapy Patients. Journal of Kunming Medical University, 2024, 45(10): 140-146. doi: 10.12259/j.issn.2095-610X.S20241022
[5]	Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy. Journal of Kunming Medical University, 2024, 45(9): 163-167. doi: 10.12259/j.issn.2095-610X.S20240925
[6]	Xiaomei JIN, Jieyan HE, Jichang SHI, Hui XING, Hong WANG, Ju ZHANG, Lijuan DONG, Lihua HUANG, Min CHEN, Zhijuan CHEN, Huichao CHEN. Virus Genotypes and Drug Resistance among HIV/AIDS Patients before Antiretroviral Therapy in Dali Bai Autonomous Prefecture in 2018. Journal of Kunming Medical University, 2023, 44(11): 152-157. doi: 10.12259/j.issn.2095-610X.S20231123
[7]	Ti WU, Kang HUANG, Zhirong ZHAO, Haiwen LI, Xiaofei LI, Yongrui YANG. The Efficacy and Safety of Different Antiviral Treatment Regimens in Patients with ALT Elevation and Low Viral Load in the Indeterminate Phase of Chronic Hepatitis B. Journal of Kunming Medical University, 2023, 44(1): 97-103. doi: 10.12259/j.issn.2095-610X.S20230117
[8]	Le ZHANG, Yuanqiang HE, Jiawei XIA, Shu LIU, Bin BAI, Xing LIU. Effect of Early Interventional Therapy with Bronchoscopic Alveolar Lavage on AIDS Patients Complicated with Severe Pneumonia. Journal of Kunming Medical University, 2022, 43(11): 151-155. doi: 10.12259/j.issn.2095-610X.S20221120
[9]	Bo TIAN, Jun LIU, Haiwen LI, Wei SONG, Haiyun CHEN, Jianjun SUN. Pathogen Distribution and Antimicrobial Susceptibility of Bacterial Bloodstream Infection in AIDS Patients. Journal of Kunming Medical University, 2022, 43(6): 140-146. doi: 10.12259/j.issn.2095-610X.S20220616
[10]	Bo TIAN, Yinzhong SHEN, Jinsong BAI, Jun LIU, Haiyun CHEN, Jianjun SUN. Clinical Characteristics of Talaromyces Marneffei Disease and Disseminated Nontuberculosis Mycobacterium Disease in AIDS Patients. Journal of Kunming Medical University, 2022, 43(7): 140-144. doi: 10.12259/j.issn.2095-610X.S20220718
[11]	Diandian ZENG, Bo TIAN, Yongmei JIN, Chongxi LI, Fen TENG, Jun LIU. A Cross-sectional Survey on Quality of Life of AIDS Patients with Different Antiretroviral Regimens in Kunming Area. Journal of Kunming Medical University, 2022, 43(12): 147-152. doi: 10.12259/j.issn.2095-610X.S20221227
[12]	Shan HUANG, Song-qin LV, Hong-fen DUAN, Jin-li SHI, Guang-min LI, Gang HUANG, Jia-neng LI, Xiao-fei LI. Cohort Study on the Influence of Opportunistic Infectious Pathogens on the Distribution of Peripheral Blood T Lymphocyte Subsets in Newly Acquired AIDS Patients During Antiretroviral Therapy. Journal of Kunming Medical University, 2021, 42(11): 159-165. doi: 10.12259/j.issn.2095-610X.S20211128
[13]	Ting-ting YU, Xiao-fei LI, Hong-ying WANG, Run-wu ZHANG, Cai-mei DING, Li-hua LI, Jing BAI, Dong-ling LI, Dong PU. Application of Viral Load Testing in Diagnosing 102 Cases of Indeterminate HIV Antibody. Journal of Kunming Medical University, 2020, 41(11): 130-133. doi: 10.12259/j.issn.2095-610X.S20201126
[14]	Zhang Lu Ping , Han Yue Hong , Chen Gui Rong , Zhang Wen Jie , Zhao Xia , Yu Xiao Mei . A Study on the Preventive Drugs for Exposure to AIDS. Journal of Kunming Medical University, 2018, 39(02): 124-127.
[15]	Yang Yong Rui , Li Fei , Yang Yin , Wen Pin Yuan , Feng Yu , Shen Jiu Cheng , Zhang Jian Qing , Shen Ling . . Journal of Kunming Medical University, 2018, 39(10): 126-129.
[16]	Lou Jin Cheng , Wu Xin Hua , Chen Xi , Lei Hong Tao , Li Tian Shu , An Liang, Lao Yun Fei . An investigation on the Dropout of Patients with HIV/AIDS Receiving Antiviral Therapy in an Area of Yunnan Province. Journal of Kunming Medical University, 2018, 39(04): 121-124.
[17]	Ma Xue Ting , Li Ya . The Analysis of T Lymphocyte Subset Among Newly-discovered HIV Infectors and Patients. Journal of Kunming Medical University, 2017, 38(11): 112-117.
[18]	Liu Jun . . Journal of Kunming Medical University,
[19]	Fu Zhong Yang . . Journal of Kunming Medical University,
[20]	Su Yun Peng . . Journal of Kunming Medical University,